INTRANASALE FORMULIERUNG MIT ROTIGOTIN
European patent · EP1605932 · Deleted
Register entry
- Publication number
- EP1605932
- Application number
- EP04804221
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Dec 22, 2004
- Published
- Dec 21, 2005
- Granted
- May 24, 2006
- Deleted
- Dec 31, 2014
- Reason
- Annual fee unpaid
- IPC classes
- A61K 31/381 (2006.01)A61P 25/16 (2006.01)
- Priority
- EP 03029680 23.12.2003
- PCT application
- PCT/EP2004/014626 22.12.2004
- PCT publication
- WO2005/063236 14.07.2005
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 22, 2015
Deleted, fee unpaid
Published in Swissreg on 22.07.2015
- Sep 1, 2010
Address changed
- Owner
- SCHWARZ PHARMA AG, Alfred-Nobel-Strasse 10, 40789 Monheim/Rhld., Germany → UCB Pharma GmbH, Alfred-Nobel-Strasse 10, 40789 Monheim, Germany
Published in Swissreg on 01.09.2010
- Oct 31, 2007
Address changed
- Representative
- E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in +pat+ No 20 in 2007
- Jul 31, 2006
Agent entered
- Representative
- E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich
Published in +pat+ No 14 in 2006
- May 31, 2006
Granted
Published in +pat+ No 10 in 2006
Parties
Inventor
KRÄMER, Robert
51109 Köln, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.